Skip to main content
Caplight Logo









mTatt

mTatt

Private
MontrealHealthcare & Life Scienceshttps://mtatt.co

Last Round

Grant

Nov 27, 2025

Total Funding Raised

$157,500

Company Overview

mTatt operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Grant round in November 2025.

mTatt is a health technology company developing an innovative microneedle patch for continuous, non-invasive monitoring of health biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Biotechnology, Sensors

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

mTatt Comparables

Compare mTatt with similar companies based on industry and business-model similarity.

mTatt comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Metyos
82%
PKvitality
79%
Biolinq
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

mTatt Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 27, 2025
AngelJul 11, 2025
GrantJun 1, 2025
GrantMar 1, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Catherine Nadeau

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

mTatt Investors

Notable investors and investment history

mTatt investors
InvestorRounds
V1 StudioGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 11, 2025

    $100K raised in Angel round.

  • Jun 1, 2025

    $50K grant received from V1 Studio.

Book a demo to see all signals

For institutional investors. Book with your work email.

mTatt Filings

Explore SEC and related filing metadata, where available.

mTatt filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about mTatt's valuation, stock price, and market status.

Is mTatt a public or private company?

mTatt is a private company.

What is the current stock price of mTatt?

mTatt is a private company, so its shares have no public market price. Caplight tracks mTatt's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is mTatt worth (valuation)?

Valuation information for mTatt is not publicly available.

Can I buy mTatt stock?

mTatt shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was mTatt's last funding round?

mTatt's most recent funding round was Grant on November 27, 2025.

Who are the main investors in mTatt?

Key investors in mTatt include V1 Studio.

Will mTatt IPO soon?

No public IPO plans have been announced for mTatt.

How can I track mTatt secondary market activity?

Caplight tracks bids, offers, and trades in mTatt's shares on secondary markets.

Firmographic Details

HeadquartersMontreal
Employee Range4
Year Founded2023
Last FundingNov 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?